PER-042-04已完成未知
Multicenter open study to investigate the safety of weekly therapy with Neorecormon in anemic patients with malignant solid tumors.
PRODUCTOS ROCHE Q.F.S.A.,0 个研究点目标入组 0 人开始时间: 2004年7月16日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •* Adult patients diagnosed with solid malignant tumor with histological confirmation
- •* Hemoglobin <11 gr / dL (<6.82 mmot / L) at the screening visit.
- •* If antineoplastic therapy is to be administered, it must be scheduled for at least 4 months from the first dose of the study treatment.
- •* Performance status according to WHO grade 0-2.
- •* Life expectancy> 6 months
- •* Written informed consent.
排除标准
- •* Transfusion of red blood cells during the 2 months prior to the first dose of the study medication.
- •* High blood pressure resistant to treatment.
- •* Relevant chronic or acute bleeding, which needed treatment within 3 months prior to the start of the study, example patient with anemia caused by gastrointestinal bleeding.
- •* Anti-tumor therapy in the week prior to the screening visit apart from corticosteroids
- •* Patients scheduled to receive bone marrow transplantation during the study period.
研究者
相似试验
已完成
不适用
Multicenter open study to investigate the safety of Weekly therapy with NeoRecormon in patients with low-grade non-Hodgkin´s lymphoma, chronic lymphocytic leukemia or Multiple Myeloma.PER-022-04PRODUCTOS ROCHE Q.F.S.A.,
进行中（未招募）
1 期
An Open Multi-centre Study to Investigate the Safety and Efficacy of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and von Willebrand Factor Concentrate, in Patients with von Willebrand Disease who are Undergoing Surgery - A Study with OPTIVATE® in von Willebrand Disease Patients Who are Having Surgeryvon Willebrand diseaseEUCTR2006-000664-85-GBBio Products Laboratory25
进行中（未招募）
1 期
An Open Multi-centre Study to Investigate the Safety and Efficacy of OPTIVATE®, a High Purity, Dual Inactivated Factor VIII and von Willebrand Factor Concentrate, in Patients with von Willebrand Disease who are Undergoing Surgeryvon Willebrand diseaseMedDRA version: 9.1Level: LLTClassification code 10047715Term: Von Willebrand's diseaseEUCTR2006-000664-85-PLBio Products Laboratory25
进行中（未招募）
不适用
Contrast-Enhanced MRI of the supra-aortic vesselsSubjects with known or suspected vascular disease of the supra-aortic vesselsMedDRA version: 16.0Level: PTClassification code 10007687Term: Carotid artery stenosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2010-023001-36-CZBayer Health Care AG398
进行中（未招募）
不适用
Contrast-Enhanced MRI of the renal arteriesEUCTR2010-023002-13-DEBayer HealthCare AG336